Biotech

All Articles

A closer consider Strong Biotech's Ferocious 15

.In this particular week's incident of "The Top Line," our experts're diving right into Intense Biot...

Lilly encounters period 2 failure of tau-targeting med

.The confetti is still soaring from Eli Lilly's celebration commemorating the commendation of Alzhei...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of significant leadership hirings, shooting...

Lykos will ask FDA to reassess its own decision complying with turndown of MDMA treatment for post-traumatic stress disorder

.Complying with a poor showing for Lykos Rehabs' MDMA candidate for post-traumatic stress disorder a...

AN 2 one-halfs census, quits phase 3 test after data let down

.AN2 Therapies is reassessing its organization in action to uninspired midphase records, vowing to l...

Merck spends $700M for bispecific, snooping autoimmune position as well as possibility to challenge Amgen in cancer

.Merck &amp Co. is paying out $700 million in advance to test Amgen in a blood stream cancer market....

Gilead pays for J&ampJ $320M to leave licensing bargain for seladelpar

.Along With Gilead Sciences about to an FDA choice for its liver condition drug seladelpar, the comp...

' All palms on deck' at Lilly as peers target weight problems market

.CEO David Ricks may find the business putting together tents at basecamp responsible for Eli Lilly ...

Entero laying off workers, vacating office as well as pausing R&ampD

.Mattress Liquidators has actually transformed Entero Rehabs white colored as a slab. The creditor b...

Exelixis loses ADC after determining it is actually no suit for Tivdak

.Exelixis is actually quiting on its own tissue factor (TF)- targeting antibody-drug conjugate after...